Navigation Links
Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors

Researchers from Mayo Clinic had developed focused ultrasound to be used in the outpatient department in the hospital for treating women suffering from uterinefibroid tumors. // Focused ultrasound is a welcome advance in treating this common condition that affects an estimated 40 percent of women over age 40, because it is the first completely noninvasive treatment available for symptoms from uterine fibroid tumors. Women leave the doctor’s office the same day, and resume activities the following day. Focused ultrasound technology relies on the precise delivery of high-energy sound waves to destroy non-cancerous tumors that have grown in the muscular wall of the uterus. Treatment is done with a magnetic resonance imaging (MRI) machine in a session that lasts about four hours. The patient is given a mild sedative before and during the procedure, and lies face down while the radiologist uses a computer to guide the MRI machine and locate the fibroids. Once the fibroids are located, high frequency, high-energy sound waves are applied. The patient may feel warmth or cramping in the pelvis. No hospitalization is necessary, and generally patients require no post-procedure pain medication, or need only simple over-the-counter pain medications after the procedure. Treatment starts in obstetrics and gynecology department where specialists determine if focused ultrasound for the patient is, in fact, her best option, and to detect any other relevant health issues. Radiologists then perform the procedure, said a resident medical practitioner from Mayo Clinic. The ideal patient being referred to Mayo Clinic for evaluation for the focused ultrasound procedure is premenopausal, in her mid-30s to mid-50s, finished childbearing, or does not desire children, inconvenienced by uterine bleeding so profuse that it soaks menstrual pads in less than two hours, and requires multiple changes throughout the day, or troubled by pelvic pressure, urinary frequency, or constipation du e to uterine fibroids Source: Newswise Medindia on Uterine Fibroids: Uterine Fibroids: These are non-cancerous tumors that are found in uterus. The cause of such a condition is unknown, while the symptoms of the condition are heavy bleeding and feeling f pressure from the uterus. Often women go for hysterectomy as a way of treatment from the condition. Keywords:
'"/>




Related medicine news :

1. Outpatient List Falls From 41,000 To 6,000
2. Max Healthcare Launches Outpatient Health Plans
3. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
4. Outpatient Cancer Care Impressive in British Columbia
5. Advances in Treatment of Cataracts
6. Recommendations for Treatment of Blood Pressue
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. More People Seeking Treatment for Depression
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 2016 , ... Since launching its annual volunteer campaign on ... footwear industry, has broken all previous participation records in its first two weeks ... during the months of April and May, the 2016 Footwear Cares initiative is ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded daily by ... and deal with these stressors is to adopt a more healthful diet, but too ... Risa Groux, a certified Holistic Nutritionist and the creator of the Newport Beach Cleanse ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... ... advocating optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") ... Radio Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Schweiz, April 27, 2016 ... CEO Forums in Zürich gab Strekin AG ... Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens von ... bekannt. Für die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe ... angeworben. STR001 wird während der Operation direkt ...
(Date:4/27/2016)... , April 27, 2016   Zillion ... its digital health technology platform, which specializes in ... programs into scalable digital products, Zillion enables companies ... and empower consumers to take control of their ... live video conferencing – including one-to-one, group and ...
(Date:4/27/2016)... 2016 Oasmia Pharmaceutical AB ... a new generation of drugs within human and ... for Paclical/Apealea in the Phase III study that ... ovarian cancer. These preliminary results showed non-inferiority between ... carboplatin versus Taxol in combination with carboplatin. In ...
Breaking Medicine Technology: